Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ANI Pharmaceuticals Inc.

www.anipharmaceuticals.com

Latest From ANI Pharmaceuticals Inc.

Deal Watch: Pfizer Begins 2018 With Two Deals, Including ALS Tie-Up With Sangamo

In addition to its latest collaboration with Sangamo, Pfizer also teams with Arvinas on protein-degradation therapies. AstraZeneca sells off four mature products to ANI, while Summit enhances its antibiotic capabilities with Discuva buyout and out-licenses Latin American rights to ridinilazole.

Deals Business Strategies

Orally Dissolving Competition Lurks For Prevacid 24HR, Other OTC PPIs

While GSK Consumer Healthcare's latest ad campaign for Prevacid 24HR features "Lurker," a fireball character who educates consumers on the risk of recurrence of heartburn, oral disintegration of an active ingredient is the latest differentiator in the OTC PPI category.

Consumer Gastrointestinal

FDA Adds New Co-Primary Endpoint For Female Sexual Desire Drugs

Draft guidance says 'associated distress' may replace number of satisfying sexual events as a co-primary efficacy endpoint.

Clinical Trials Drug Approval Standards

Clinical Trial Success Rates Still Dismal, But Certain Sectors Outperform

The high risk-high reward nature of drug development is a constant challenge to pharma. Informa's Pharma Intelligence teamed up with BIO and Amplion to provide an update on clinical development success rates from 2006 to 2015, including a new analysis on trials incorporating patient selection biomarkers.

Market Intelligence Innovation
See All

Company Information

  • Industry
  • Contract Research, Toxicology Testing-CRO
  • Pharmaceuticals
    • Generic Drugs
  • Services
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • ANIP Acquisition Co.
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • ANI Pharmaceuticals Inc.
  • Senior Management
  • Arthur S Przybyl, Pres. & CEO
    Stephen P Carey, VP, CFO
    Robert W Schrepfer, SVP, Bus. Dev. & Spec. Sales
  • Contact Info
  • ANI Pharmaceuticals Inc.
    Phone: (218) 634-3500
    210 Main St. W.
    Baudette, MN 56623
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register